REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 157.50
Bid: 150.00
Ask: 165.00
Change: 0.00 (0.00%)
Spread: 15.00 (10.00%)
Open: 157.50
High: 157.50
Low: 157.50
Prev. Close: 157.50
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strong Revenue Momentum and Extended Funding

5 May 2020 07:00

RNS Number : 8934L
Itaconix PLC
05 May 2020
 

5 May 2020

Itaconix plc ("Itaconix" or the "Company")

Strong Revenue Momentum and Extended Funding

Itaconix (LSE:ITX) (OTCQB:ITXXF) announces that, further to the update provided on 17 March 2020, the Company has made significant progress in its operational efforts to extend the Company's cash runway, with operating expenses reduced and new payments terms with key customers and suppliers negotiated.

Whilst ensuring that the Company maintains production capabilities, several actions have also been taken to reduce costs and maintain liquidity, including:

· John R. Shaw, CEO, agreeing to a voluntary 65% deferral in cash compensation until at least the end of August 2020;

· Other executives agreeing to a voluntary 50% deferral in cash compensation until at least the end of August 2020;

· The Non-Executive Directors agreeing to a voluntary 75% deferral in cash compensation until at least the end of the September 2020; and

· The curtailment of all non-essential discretionary spending.

In addition to cost savings, the Company has applied for COVID-19 US government relief programs available for its US operations. To date, the Company has received a $10,000 grant from the US government and continues to seek additional funds from this source. Cash at 30 April 2020 was $0.3 million.

The Board believes that, with these actions and without any further funding (including any further funding received from COVID-19 US Government relief programs being applied for), the Company now has sufficient working capital to operate until at least the end of August 2020. The Company is continuing to develop and evaluate additional equity and debt funding proposals.

Trading Update

The Board also announces that revenues for the first four months of 2020 were $0.6m, representing an increase of 42% over the same period in 2019. The strong growth is primarily from the continued commercial progress and success of the Company's detergent polymers including:

· Receipt of first purchase order for Itaconix® TSI322 to support the launch of a new dishwashing detergent under a major brand in North America by New Wave. The new detergent product is expected to be in retail stores across the United States in the coming weeks.

· Total volumes under the New Wave supply agreement are ahead of plan.

· Order volumes increased from existing customers in response to higher demand for dishwashing detergents related to stay-at-home orders issued by governments to contain the spread of COVID-19.

 

The Board expects continued revenue growth for the Company's detergent polymers.

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

Ends

For further information please contact:

Itaconix

+1 (603) 775 4400

 

John R. Shaw / Laura Denner

N+1 Singer

+44 (0) 207 496 3000

Peter Steel / James Moat (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

About Itaconix

Itaconix plc (LSE: ITX) is a leading innovator in bio-based functional ingredients for improving the safety and performance of homecare, personal care, and industrial products. Its proprietary polymer technology generates a growing range of new ingredients with unique functionality that meet consumer demands for value and sustainability.

www.itaconix.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDBGDUBGGDGGS
Date   Source Headline
8th Jun 20229:04 amRNSFinal Results - replacement
8th Jun 20227:30 amRNSTR-1
8th Jun 20227:00 amRNSFinal Results
6th Jun 20222:00 pmRNSPrice Monitoring Extension
27th May 20227:00 amRNSNotice of Final Results, Presentation and AGM
22nd Apr 20227:00 amRNSNew Funding to Support EU Volumes
20th Apr 20227:00 amRNSTrading Update
19th Apr 20227:00 amRNSBoard Changes
29th Mar 202211:05 amRNSSecond Price Monitoring Extn
29th Mar 202211:00 amRNSPrice Monitoring Extension
22nd Feb 20224:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20224:35 pmRNSPrice Monitoring Extension
16th Feb 20224:41 pmRNSSecond Price Monitoring Extn
16th Feb 20224:36 pmRNSPrice Monitoring Extension
16th Feb 20227:00 amRNSInvestor Event
9th Feb 202211:06 amRNSSecond Price Monitoring Extn
9th Feb 202211:00 amRNSPrice Monitoring Extension
9th Feb 20227:00 amRNSFirst Trial for Sustainable Superabsorbent
3rd Feb 20227:00 amRNSNew Patent Filed for Plant-Based Ingredient
26th Jan 20222:05 pmRNSSecond Price Monitoring Extn
26th Jan 20222:00 pmRNSPrice Monitoring Extension
26th Jan 20227:00 amRNSTrading Update
10th Jan 20227:15 amRNSInitiation of Research
22nd Dec 20217:00 amRNSFirst Order for New Use in Sustainable Fashion
21st Dec 20219:05 amRNSSecond Price Monitoring Extn
21st Dec 20219:00 amRNSPrice Monitoring Extension
21st Dec 20217:00 amRNSStatement re Production Resumption
9th Dec 202111:06 amRNSSecond Price Monitoring Extn
9th Dec 202111:00 amRNSPrice Monitoring Extension
4th Nov 20217:00 amRNSProduction Interruption from Storm Damage
1st Oct 20214:41 pmRNSSecond Price Monitoring Extn
1st Oct 20214:36 pmRNSPrice Monitoring Extension
1st Oct 20212:05 pmRNSSecond Price Monitoring Extn
1st Oct 20212:00 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSInterim Results
23rd Sep 20214:41 pmRNSSecond Price Monitoring Extn
23rd Sep 20214:36 pmRNSPrice Monitoring Extension
23rd Sep 20217:00 amRNSNotice of Interim Results & Investor Presentation
16th Sep 202112:13 pmRNSSecond Price Monitoring Extn
16th Sep 202112:12 pmRNSSecond Price Monitoring Extn
16th Sep 202112:12 pmRNSPrice Monitoring Extension
14th Sep 20214:41 pmRNSSecond Price Monitoring Extn
14th Sep 20214:36 pmRNSPrice Monitoring Extension
14th Sep 202111:06 amRNSSecond Price Monitoring Extn
14th Sep 202111:01 amRNSPrice Monitoring Extension
9th Sep 20217:00 amRNSFirst EU Order for Latest Detergent Ingredient
26th Aug 20217:00 amRNSChange of Adviser
27th Jul 20219:05 amRNSSecond Price Monitoring Extn
27th Jul 20219:00 amRNSPrice Monitoring Extension
27th Jul 20217:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.